M&A Deal Summary

Bio-Rad Acquires Stilla

On February 13, 2025, Bio-Rad acquired medical products company Stilla

Acquisition Highlights
  • This is Bio-Rad’s 2nd transaction in the Medical Products sector.
  • This is Bio-Rad’s 1st transaction in France.

M&A Deal Summary

Date 2025-02-13
Target Stilla
Sector Medical Products
Buyer(s) Bio-Rad
Deal Type Add-on Acquisition

Target

Stilla

Villejuif, France
Stilla develops and markets next-generation digital PCR instruments, consumables, and assays. The company’s Nio® family of all-in-one droplet digital PCR systems aids the development of a wide range of genetic tests and molecular assays across multiple applications including liquid biopsy for oncology diagnostics, cell and gene therapy, organ transplant testing, infectious diseases, and food and environmental testing. Stilla was formed in 2013 and is headquartered in Villejuif, France.

Search 214,981 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bio-Rad

Hercules, California, United States

Category Company
Founded 1952
Sector Medical Products
Employees7,700
Revenue 2.6B USD (2024)
DESCRIPTION

Bio-Rad is a developer, manufacturer, and marketer of a broad range of medical tools and services to the life science research and clinical diagnostics markets. Bio-Rad was incorporated in 1952 and is based in Hercules, California.


DEAL STATS #
Overall 9 of 9
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 7 of 7
Country: France M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-03 Curiosity Diagnostics

Warsaw, Poland

Curiosity Diagnostics is a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market. Curiosity Diagnostics was founded in 2012 and is based in Warsaw, Poland.

Buy $170M